Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Clinical Trial ID NCT02684253

PubWeight™ 3.09‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02684253

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016 0.81
2 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
3 Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma. Oncoimmunology 2016 0.77
4 Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2016 0.75
Next 100